Targeting of the AKT/m-TOR Pathway: Biomarkers of Resistance to Cancer Therapy——AKT/m-TOR Pathway and Resistance to Cancer Therapy

Resistance to cancer therapy continues to be a major limitation for the successful treatment of cancer. There are many published studies on therapy resistance in breast and prostate cancers; however, there are currently no data on molecular markers associated with resistance. The conflicting data we...

Descripción completa

Detalles Bibliográficos
Autores principales: SPIRINA, Liudmila V, KONDAKOVA, Irina V, TARASENKO, Natalia V, SLONIMSKAYA, Elena M, USYNIN, Evgeny A, GORBUNOV, Alexey K, YURMAZOV, Zahar A, CHIGEVSKAYA, Svetlana Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2018
Materias:
Mini-Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972354/
https://www.ncbi.nlm.nih.gov/pubmed/29357975
http://dx.doi.org/10.3779/j.issn.1009-3419.2018.01.09

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972354/
https://www.ncbi.nlm.nih.gov/pubmed/29357975
http://dx.doi.org/10.3779/j.issn.1009-3419.2018.01.09

Ejemplares similares